+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Local Anesthesia Drugs Market by Drugs Type, Application: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 260 Pages
  • February 2023
  • Region: Global
  • Allied Market Research
  • ID: 5781716
Description Jump to:
The global local anesthesia drugs market size was $2,643.50 million in 2021 and is predicted to grow with a CAGR of 6.4%, by generating a revenue of $4,724.80 million by 2031.

The global market for local anesthetic medications is expanding as a result of an increase in surgeries, particularly those related to accidents and chronic illnesses like cancer, cardiovascular disease, and orthopedic disorders. Additionally, there are more injuries now that need medical attention. As per analysis, more than 5 million were hurt in collisions in North America and were seeking medical attention in 2020. These factors are projected to boost the local anesthesia market size during the forecast period.

Anesthesia is defined as a loss of feeling with or without loss of consciousness and can be effectively attained with a vast variety of medications with incredibly complex chemical structures. There are numerous central nervous system (CNS) depressants on the list of such substances, in addition to the traditional anesthetic agents like general and local anesthetics, as well as analgesics, sedative/hypnotics anticonvulsants, and skeletal muscle relaxants. Although each of these substances has a different mode of action, they all ultimately generate anesthetic effects by interfering with the conduction of sensory neurons and, occasionally, motor neurons. Today, several of these substances are frequently employed in clinical settings to speed up operations and other medical procedures. As a result, this will increase demand for the local anesthesia market.

In addition, the creation and approval of new local anesthetic medications is proving to be a new source of income for market participants. According to the United Nations Department of Economic and Social Affairs, one in four residents of Europe and North America maybe 65 years of age or older by 2050. Chronic illnesses like cardiovascular and neurological conditions are becoming more prevalent in older populations as a result of the growing geriatric population, which drives up the demand for local anesthesia medications.

However, the absence of healthcare facilities in undeveloped nations and distant regions, as well as the shortage of anesthesia doctors and certified anesthesia nurses per capita, are likely to hinder the expansion of the local anesthesia drugs market. Other branded drugs, lack of awareness among patients, and high costs of procedures may further restrain the expansion of this market over the predicted period.

Additionally, one or two patients out of every 1000 who receive general anesthesia during surgery may not be aware that they are partially awake. Although there is a very low likelihood that one might feel discomfort, it is possible. People who get sedative medications before surgery are unable to move, express their anguish, or alert the medical staff. It's possible that patients will experience long-term psychological issues as a result, akin to post-traumatic stress disorder. Unintentional intraoperative awareness is what this is, and it's one of the biggest issues facing the anesthesia market.

Surgical procedures are difficult and painful so as giving anesthesia, currently, research is going on to make local anesthetic application less painful. An injection of local anesthetic causes a burning sensation because it contains an acidic solution. Current research is examining the advantages of developing a more neutral solution to make the anesthetic injection procedure more pleasant. One formula under investigation involves adding sodium bicarbonate to the lidocaine and epinephrine solution. Theoretically, this neutral local anesthetic solution offers two benefits: a less painful injection and a quicker start to desensitization. It is impossible to emphasize the value of local anesthetics. Today's surgical and dental treatments would require more invasive techniques to make patients comfortable if local anesthetics were not used. The discipline of local anesthetics will continue to advance in the never-ending hunt for pain relief with sustained research and innovation.

The key players profiled in this report include Novartis AG, Aspen Pharmacare, Sagent Pharmaceuticals, Pacira Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi, Mylan N.V., GSK plc., AstraZeneca plc, and Hikma Pharmaceuticals plc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the local anesthesia drugs market analysis from 2021 to 2031 to identify the prevailing local anesthesia drugs market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the local anesthesia drugs market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global local anesthesia drugs market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Drugs Type

  • Bupivacaine
  • Ropivacaine
  • Lidocaine
  • Chloroprocaine
  • Prilocaine
  • Benzocaine
  • Other local anesthetics

By Application

  • Injectable
  • Surface Anesthetic

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • United Arab Emirates
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Fresenius Kabi AG
  • Novartis AG
  • Aspen Holdings
  • Sagent Pharmaceuticals
  • Pacira Pharmaceuticals, Inc.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Septodont Healthcare India Pvt. Ltd.
  • Baxter International Inc.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Key Regulation Analysis
3.7. Market Share Analysis
3.8. Patent Landscape
3.9. Regulatory Guidelines
3.10. Value Chain Analysis
CHAPTER 4: LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Bupivacaine
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Ropivacaine
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Lidocaine
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Chloroprocaine
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Prilocaine
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Benzocaine
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
4.8. Other local anesthetics
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market share analysis by country
CHAPTER 5: LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Injectable
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Surface Anesthetic
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: LOCAL ANESTHESIA DRUGS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Drugs Type
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Drugs Type
6.2.4.1.3. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Drugs Type
6.2.4.2.3. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Drugs Type
6.2.4.3.3. Market size and forecast, by Application
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Drugs Type
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Drugs Type
6.3.4.1.3. Market size and forecast, by Application
6.3.4.2. UK
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Drugs Type
6.3.4.2.3. Market size and forecast, by Application
6.3.4.3. France
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Drugs Type
6.3.4.3.3. Market size and forecast, by Application
6.3.4.4. Spain
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Drugs Type
6.3.4.4.3. Market size and forecast, by Application
6.3.4.5. Italy
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Drugs Type
6.3.4.5.3. Market size and forecast, by Application
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Drugs Type
6.3.4.6.3. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Drugs Type
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Drugs Type
6.4.4.1.3. Market size and forecast, by Application
6.4.4.2. Japan
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Drugs Type
6.4.4.2.3. Market size and forecast, by Application
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Drugs Type
6.4.4.3.3. Market size and forecast, by Application
6.4.4.4. South Korea
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Drugs Type
6.4.4.4.3. Market size and forecast, by Application
6.4.4.5. Australia
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Drugs Type
6.4.4.5.3. Market size and forecast, by Application
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Drugs Type
6.4.4.6.3. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Drugs Type
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Drugs Type
6.5.4.1.3. Market size and forecast, by Application
6.5.4.2. United Arab Emirates
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Drugs Type
6.5.4.2.3. Market size and forecast, by Application
6.5.4.3. Saudi Arabia
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Drugs Type
6.5.4.3.3. Market size and forecast, by Application
6.5.4.4. South Africa
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Drugs Type
6.5.4.4.3. Market size and forecast, by Application
6.5.4.5. Rest of LAMEA
6.5.4.5.1. Key market trends, growth factors and opportunities
6.5.4.5.2. Market size and forecast, by Drugs Type
6.5.4.5.3. Market size and forecast, by Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Fresenius Kabi AG
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.2. Novartis AG
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.3. Aspen Holdings
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.4. Sagent Pharmaceuticals
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.5. Pacira Pharmaceuticals, Inc.
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.6. Mylan N.V.
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.7. Teva Pharmaceutical Industries Ltd.
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.8. Pfizer Inc.
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.9. Septodont Healthcare India Pvt. Ltd.
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.10. Baxter International Inc.
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
List of Tables
TABLE 01. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 02. LOCAL ANESTHESIA DRUGS MARKET FOR BUPIVACAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 03. LOCAL ANESTHESIA DRUGS MARKET FOR ROPIVACAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 04. LOCAL ANESTHESIA DRUGS MARKET FOR LIDOCAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 05. LOCAL ANESTHESIA DRUGS MARKET FOR CHLOROPROCAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 06. LOCAL ANESTHESIA DRUGS MARKET FOR PRILOCAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 07. LOCAL ANESTHESIA DRUGS MARKET FOR BENZOCAINE, BY REGION, 2021-2031 ($MILLION)
TABLE 08. LOCAL ANESTHESIA DRUGS MARKET FOR OTHER LOCAL ANESTHETICS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 10. LOCAL ANESTHESIA DRUGS MARKET FOR INJECTABLE, BY REGION, 2021-2031 ($MILLION)
TABLE 11. LOCAL ANESTHESIA DRUGS MARKET FOR SURFACE ANESTHETIC, BY REGION, 2021-2031 ($MILLION)
TABLE 12. LOCAL ANESTHESIA DRUGS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 13. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 14. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 15. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. U.S. LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 17. U.S. LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 18. CANADA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 19. CANADA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 20. MEXICO LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 21. MEXICO LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 22. EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 23. EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. GERMANY LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 26. GERMANY LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 27. UK LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 28. UK LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 29. FRANCE LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 30. FRANCE LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 31. SPAIN LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 32. SPAIN LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 33. ITALY LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 34. ITALY LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 35. REST OF EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 36. REST OF EUROPE LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 38. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 39. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 40. CHINA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 41. CHINA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 42. JAPAN LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 43. JAPAN LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. INDIA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 45. INDIA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 46. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 47. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 48. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 49. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. REST OF ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 52. LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 53. LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 54. LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 55. BRAZIL LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 56. BRAZIL LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 58. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 60. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 62. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. REST OF LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021-2031 ($MILLION)
TABLE 64. REST OF LAMEA LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 65. FRESENIUS KABI AG: KEY EXECUTIVES
TABLE 66. FRESENIUS KABI AG: COMPANY SNAPSHOT
TABLE 67. NOVARTIS AG: KEY EXECUTIVES
TABLE 68. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 69. ASPEN HOLDINGS: KEY EXECUTIVES
TABLE 70. ASPEN HOLDINGS: COMPANY SNAPSHOT
TABLE 71. SAGENT PHARMACEUTICALS: KEY EXECUTIVES
TABLE 72. SAGENT PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 73. PACIRA PHARMACEUTICALS, INC.: KEY EXECUTIVES
TABLE 74. PACIRA PHARMACEUTICALS, INC.: COMPANY SNAPSHOT
TABLE 75. MYLAN N. V.: KEY EXECUTIVES
TABLE 76. MYLAN N. V.: COMPANY SNAPSHOT
TABLE 77. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
TABLE 78. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 79. PFIZER INC.: KEY EXECUTIVES
TABLE 80. PFIZER INC.: COMPANY SNAPSHOT
TABLE 81. SEPTODONT HEALTHCARE INDIA PVT. LTD.: KEY EXECUTIVES
TABLE 82. SEPTODONT HEALTHCARE INDIA PVT. LTD.: COMPANY SNAPSHOT
TABLE 83. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 84. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
List of Figures
FIGURE 01. LOCAL ANESTHESIA DRUGS MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF LOCAL ANESTHESIA DRUGS MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN LOCAL ANESTHESIA DRUGS MARKET (2022-2031)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALLOCAL ANESTHESIA DRUGS MARKET
FIGURE 10. IMPACT OF KEY REGULATION: LOCAL ANESTHESIA DRUGS MARKET
FIGURE 11. MARKET SHARE ANALYSIS: LOCAL ANESTHESIA DRUGS MARKET
FIGURE 12. PATENT ANALYSIS BY COMPANY
FIGURE 13. PATENT ANALYSIS BY COUNTRY
FIGURE 14. REGULATORY GUIDELINES: LOCAL ANESTHESIA DRUGS MARKET
FIGURE 15. VALUE CHAIN ANALYSIS: LOCAL ANESTHESIA DRUGS MARKET
FIGURE 16. LOCAL ANESTHESIA DRUGS MARKET, BY DRUGS TYPE, 2021 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR BUPIVACAINE, BY COUNTRY 2021-2031 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR ROPIVACAINE, BY COUNTRY 2021-2031 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR LIDOCAINE, BY COUNTRY 2021-2031 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR CHLOROPROCAINE, BY COUNTRY 2021-2031 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR PRILOCAINE, BY COUNTRY 2021-2031 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR BENZOCAINE, BY COUNTRY 2021-2031 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR OTHER LOCAL ANESTHETICS, BY COUNTRY 2021-2031 (%)
FIGURE 24. LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION, 2021 (%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR INJECTABLE, BY COUNTRY 2021-2031 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF LOCAL ANESTHESIA DRUGS MARKET FOR SURFACE ANESTHETIC, BY COUNTRY 2021-2031 (%)
FIGURE 27. LOCAL ANESTHESIA DRUGS MARKET BY REGION, 2021
FIGURE 28. U.S. LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 29. CANADA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 30. MEXICO LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 31. GERMANY LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 32. UK LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 33. FRANCE LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 34. SPAIN LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 35. ITALY LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 36. REST OF EUROPE LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 37. CHINA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 38. JAPAN LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 39. INDIA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 40. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 41. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 42. REST OF ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 43. BRAZIL LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 44. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 45. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 46. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 47. REST OF LAMEA LOCAL ANESTHESIA DRUGS MARKET, 2021-2031 ($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52. COMPETITIVE DASHBOARD
FIGURE 53. COMPETITIVE HEATMAP: LOCAL ANESTHESIA DRUGS MARKET
FIGURE 54. TOP PLAYER POSITIONING, 2021

Executive Summary

According to the report titled, “Local Anesthesia Drugs Market," the local anesthesia drugs market was valued at $2.6 billion in 2021, and is estimated to reach $4.7 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031.

Local anesthesia drugs inhibit the excitation of nerves endings by blocking the conduction in peripheral nerves owing to which they help in reducing pain sensation. Local anesthesia drugs help in preventing the pain caused by certain medical procedures such as biopsy, cancer-related pain, open sores, rashes, and ivy contact. Also, these drugs are used during labor pain where the doctor may provide epidural anesthesia. With local anesthesia drugs only the body part is numb while the patient is still conscious and alert. Local anesthesia drugs are safer than general anesthesia drugs and opioids. Local anesthesia drugs are also used during dental procedures such as tooth extraction.

Healthcare professionals consider several factors while deciding whether to use local anesthesia drugs or general anesthesia drugs. For instance, if the medical procedure is minor like stitching the wound then local anesthesia drugs can be used. When there is no need for patient to become unconscious or when there is no need to relax muscles, local anesthesia drugs can be used. Also, when the procedure is quick and does not need to stay overnight, these drugs can be used. Furthermore, several factors are considered for deciding which dose of anesthesia should be given based on person’s age, medical conditions, weight, allergies, aim of procedure, and others.

Local anesthesia drugs offer several advantages that relieves pain without major side-effects. Local anesthesia can be used in three different ways. This includes local anesthesia drugs via local application, nerve blocks, and local injection. The local application means local anesthetic ointment is applied to mouth ulcers or open sores to reduce the pain or for minor operations. In local injection, the anesthetic drug is injected under the skin. In such injections, one does not feel needle pricks as doctor sews a wound. The local anesthesia drugs wear off quickly and to prolong the effect of local anesthesia other drugs like clonidine, steroids, and epinephrine are used. Local anesthesia offers relief from pain including labor pain, joint pain, and others. Some of the popular over the counter (OTC) topical anesthetics help in managing pain related to minor burns, sore throat, tooth, gum, bug bites, hemorrhoids, and others. These factors are anticipated to boost the local anesthesia drug market share during the forecast period.

Local anesthesia drugs can cause soreness, tingling feeling, headache, blood pressure, and others which is estimated to restrict the market growth. In some cases, these drugs can also result in allergic reaction that can cause itching, hives, and breathing difficulties.

The growing popularity of local anesthesia drugs and its use in carpal tunnel release, discectomy, breast lumpectomy, and stool removal is anticipated to generate excellent opportunities in the market. Local anesthesia is very safe compared to general anesthesia. Also, the local anesthesia in topical treatment can be used for anything involving a needle poke, applying or removing stitches, endoscopy, cataract surgery, IV insertion, laser treatments, and others. The injectable local anesthetics are widely used for pain management especially during pacemaker insertion, root canal, deep wart removal, bone marrow biopsy, lumbar puncture, and others. These factors will drive excellent opportunities in the local anesthesia drugs market.

The local anesthesia drugs market is segmented on the basis of drugs type, application, and region. On the basis of drug type, the market is classified into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and other local anesthetics. As per application, it is divided into injectable, and surface anesthetic. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, UAE, South Africa, and rest of LAMEA).

The key players profiled in the study include Novartis AG, Aspen Pharmacare, Sagent Pharmaceuticals, Pacira Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi, Mylan N.V., GSK plc., AstraZeneca plc, and Hikma Pharmaceuticals plc. The major players in the market have been actively engaged in the adoption of various strategies such as acquisition, product launch, and expansion to remain competitive and gain an advantage over the competitors in the market. For instance, in January 2020, Novartis, the leading pharmaceutical company, has completed the acquisition of The Medicines Company.

Key Market Insights

  • By drugs type, the lidocaine segment was the highest revenue contributor to the market in 2021 and bupivacaine is estimated to be the fastest growing during the forecast period.
  • As per application, the injectable segment was the highest revenue contributor to the market in 2021 and surface anesthetic is projected to be the fastest growing segment during the forecast period.
  • Based on region, North America was the highest revenue contributor in the market, accounting for $1,099.7 million in 2021 and is anticipated to generate a CAGR of 5.9% during the forecast period.

Companies Mentioned

  • Fresenius Kabi AG
  • Novartis AG
  • Aspen Holdings
  • Sagent Pharmaceuticals
  • Pacira Pharmaceuticals, Inc.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Septodont Healthcare India Pvt. Ltd.
  • Baxter International Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

Local Anesthesia Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Local Anesthesia Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Local Anesthesia Drugs Market by Drug Type, Type, Mode of Administration, Distribution Channel, End-Use - Global Forecast 2025-2030 - Product Image

Local Anesthesia Drugs Market by Drug Type, Type, Mode of Administration, Distribution Channel, End-Use - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Local Anesthesia Drugs - Global Strategic Business Report - Product Image

Local Anesthesia Drugs - Global Strategic Business Report

  • Report
  • 94 Pages
  • Global
From
Local Anesthesia Drugs Global Market Report 2024 - Product Image

Local Anesthesia Drugs Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Local Anesthesia Drugs Market Size, Share & Trends Analysis Report By Drug (Bupivacaine, Ropivacaine, Lidocaine), By Application (Injectable, Surface Anesthetic), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Local Anesthesia Drugs Market Size, Share & Trends Analysis Report By Drug (Bupivacaine, Ropivacaine, Lidocaine), By Application (Injectable, Surface Anesthetic), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.